LG37675-2Oxycodone+Oxymorphone|
Basic Attributes
- Version First Released
- Pending promotion to Production status
- Parent Group
-
LG80-4 Drug/ToxPotentialForAbuse<SAME:Comp><ROLLUP:Prop|
Tm| Sys| Meth> - Group Category
- Drugs of abuse
LOINC FHIR® API Example - ValueSet Request Get Info
https://fhir.loinc.org/ValueSet/?url=http://loinc.org/vs/LG37675-2
LOINC Terms in this Group
| 58430-0 | oxyCODONE+oxyMORphone [Presence] in Urine by Screen method |
| 61197-0 | oxyCODONE+oxyMORphone [Presence] in Urine by Confirmatory method |
| 71430-3 | oxyCODONE+oxyMORphone [Presence] in Saliva (oral fluid) by Screen method |
| 74658-6 | oxyCODONE+oxyMORphone [Presence] in Saliva (oral fluid) by Confirmatory method |
| 77731-8 | oxyCODONE+oxyMORphone [Interpretation] in Serum, Plasma or Blood Qualitative by Confirmatory method |
| 77732-6 | oxyCODONE+oxyMORphone [Presence] in Serum, Plasma or Blood by Screen method |
| 91032-3 | oxyCODONE+oxyMORphone [Presence] in Meconium by Screen method |
| 91044-8 | oxyCODONE+oxyMORphone [Presence] in Body fluid by Screen method |
| 91053-9 | oxyCODONE+oxyMORphone [Presence] in Tissue by Screen method |
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright